Using DNA repair and machine learning to improve cancer risk prediction
Scientists are harnessing machine learning to make accurate measurements of breast cancer risk from a patient’s blood cells
Scientists are harnessing machine learning to make accurate measurements of breast cancer risk from a patient’s blood cells
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers
Your guide to choosing and implementing the best automated solutions for the clinical laboratory
To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work
CellaVision integration with HORIBA’s HELO automated hematology platform enables unique two-way data flow and rapid results validation
Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus
Register for this webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
Assay will help guide treatment decisions in cases of non-small cell lung cancer
Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11
Collaboration will enable global development, manufacturing and distribution of the vaccine
The test will be available for qualified laboratories across the European Union by the end of May
Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease
The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa
The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2
Alliance for the scale-up of a GMP manufacturing process and production of a coronavirus (SARS-CoV-2) vaccine (ChAdOx1 nCoV-19) formed
The collaboration aims to develop novel, targeted treatments to address significant unmet needs
Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development
AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19
The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.
The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA